Allergy Archives - Page 4 of 8 - Hospital Healthcare EuropeHospital Healthcare Europe

This website is intended for healthcare professionals only!

Allergy

European Commission approval for self-administration of Xolair® across all indications

European Commission approval for self-administration of Xolair® across all indications

How does diet during pregnancy impact allergies in offspring?

How does diet during pregnancy impact allergies in offspring?

Phase II enrollment for therapeutic vaccine candidate in patients with coeliac disease

Phase II enrollment for therapeutic vaccine candidate in patients with coeliac disease

Three in 10 drug-related deaths in acute care due to omitted medicines

Three in 10 drug-related deaths in acute care due to omitted medicines, research reveals

Accuracy in predicting patient outcomes in milk oral immunotherapy

Accuracy in predicting patient outcomes in milk oral immunotherapy

Towards a treatment for gluten intolerance

Towards a treatment for gluten intolerance

Research shows that environmental exposures early in life modify immune responses

Research shows that environmental exposures early in life modify immune responses

A hope for fish allergy sufferers?

A hope for fish allergy sufferers?

New drug could reduce risk of allergic reaction to peanuts in children and adolescents

New drug could reduce risk of allergic reaction to peanuts in children and adolescents

Results of landmark PALISADE trial published in New England Journal of Medicine

Results of landmark PALISADE trial published in New England Journal of Medicine

Test predicts outcomes of hay fever therapies

Test predicts outcomes of hay fever therapies

New EpiPen junior validation process mandated following ‘critical’ shortages in UK

New EpiPen junior validation process mandated following ‘critical’ shortages in UK

Initiative launched to improve people's understanding of eczema

Initiative launched to improve people’s understanding of eczema

NICE issues draft guidance not recommending dupilumab

NICE issues draft guidance not recommending dupilumab

Omalizumab recommended in global chronic urticaria guideline

Omalizumab recommended in global chronic urticaria guideline